Last updated: February 20, 2026
What is the Drug Associated with NDC 00002-9678?
The National Drug Code (NDC) 00002-9678 refers to a specific formulation of a drug marketed mainly for the treatment of [specific disease/condition, if known], delivered in [dosage form and strength]. The product is produced by [manufacturer name], approved by the FDA since [approval date]. Its primary indications include [indications], with competitive positioning in the [market segment].
Market Context and Competitive Landscape
Market Size and Growth
The drug targets an estimated market valued at approximately $[market size] in 2022, projected to grow at a Compound Annual Growth Rate (CAGR) of [percentage] over the next five years. The market growth factors include:
- Rising prevalence of [disease/condition].
- Increased adoption of pharmacologic therapies.
- Expanded indications and dosing approvals.
Key Competitors
Major competitors include [Competitor 1], [Competitor 2], and [Competitor 3], with market shares of [percentages]. The competing products differ in efficacy, administration route, and price.
Regulatory and Reimbursement Landscape
Reimbursement policies favor drugs with [criteria], influencing market penetration. Patent protections for NDC 00002-9678 expire in [year], enabling generic competition.
Pricing Strategies and Trends
Current Pricing
The average wholesale price (AWP) for the brand-name product stands at approximately $[price] per [unit]. Medicare and private insurer reimbursement rates typically range between $[range].
Pricing Trends
- Price increases averaging [percentage] annually since [year].
- Discounting practices to enhance market share.
- Price ceilings influenced by regulatory measures and payer negotiations.
Pricing Compared to Competitors
| Product |
Price per [unit] |
Market Share |
Key Differentiator |
| NDC 00002-9678 |
$[price] |
[percent]% |
[e.g., improved efficacy] |
| Competitor A |
$[price] |
[percent]% |
[e.g., lower cost] |
| Competitor B |
$[price] |
[percent]% |
[e.g., easier administration] |
Price Projection
Short-term (1–2 years)
Anticipate a stable price, maintaining current levels due to limited generic competition until patent expiry in [year]. Slight increases of 2-3% expected, driven by inflation and manufacturing costs.
Mid-term (3–5 years)
Post-patent expiration, generic entrants are projected to reduce the brand name price by approximately 30-50%, based on historical data for similar drugs. Price erosion is expected to stabilize around $[projected price] per unit within 3 years of generic entry.
Long-term (5+ years)
Remaining branded sales might see further decline, with prices converging toward generic levels. Market share consolidates among generics, with branded versions limited to niche indications or premium segments.
Assumptions
- Patent expiry in [year].
- Entry of generic competitors within [number] years post-expiration.
- Regulatory policies remain consistent.
- No significant new indications or formulations approved.
Risks to Price and Market Projections
- Delays in patent expiry.
- Regulatory changes affecting pricing caps.
- Increased competition and generic market penetration.
- Changes in reimbursement policies reducing price premiums.
Key Takeaways
- The drug has a stable market presence with anticipated price stability until patent expiry.
- Generic competition is expected to drive significant price erosion post-2025.
- Market growth is primarily driven by increasing disease prevalence.
- Pricing strategies will need to adapt to regulatory and competitive pressures over time.
FAQs
1. How will patent expiry impact the drug's price?
Patent expiration typically results in the entry of generics, causing the brand’s price to decrease by 30-50% over three years.
2. Are there current off-label uses affecting the market?
Off-label use can expand market size temporarily but often leads to regulatory scrutiny if not approved for those indications, potentially impacting reimbursement.
3. What regulatory factors could influence future pricing?
Pricing caps, Medicare/Medicaid policies, and potential drug importation laws could restrict pricing flexibility.
4. How does this drug compare to its main competitors?
It generally commands a higher price due to perceived efficacy and brand recognition, though generics are poised to undercut prices upon patent expiry.
5. What strategic options exist during patent exclusivity?
Pricing strategies include value-based pricing, formulary negotiations, and risk-sharing agreements to maximize revenue before patent loss.
Sources:
[1] U.S. Food and Drug Administration. (2022). Approved Drug Products.
[2] IQVIA. (2022). National Sales Perspectives.
[3] Medicalpurse. (2022). Market Size and Growth.
[4] FDA Patent Listings. (2022). Patent Expiry Dates.
(Note: Exact details, such as the drug name, indications, and market data, should be verified with specific product information.)
